- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Bicara Therapeutics
Total 6489 results
-
Vivoryon Therapeutics N.V.National Institute on Aging (NIA); Alzheimer's Disease Cooperative Study (ADCS)RecruitingAlzheimer DiseaseUnited States
-
Nicholas ButowskiNational Cancer Institute (NCI); Celldex TherapeuticsTerminatedGlioma | Malignant Glioma | Oligodendroglioma | Astrocytoma, Grade II | Glioma, Astrocytic | Oligoastrocytoma, MixedUnited States
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; Geneos TherapeuticsActive, not recruitingGlioblastomaUnited States
-
Zai Lab (Shanghai) Co., Ltd.Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid TumorChina
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, Inc; Whittier FoundationTerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia and other conditionsUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Helsinn Therapeutics (U.S.), IncCompleted
-
Xinhua Hospital, Shanghai Jiao Tong University...CARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
Pancreatic Cancer Research TeamMerck Sharp & Dohme LLC; University of Washington; Halozyme TherapeuticsUnknownPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Seattle Children's HospitalChildren's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...CompletedAML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDSUnited States, Canada
-
Cascadian Therapeutics Inc.National Cancer Institute (NCI); Translational Genomics Research InstituteTerminatedPancreatic NeoplasmsUnited States
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsCompletedSpinal Cord InjuryUnited States
-
Brian Jerkins, MDOcular Therapeutix, Inc.Not yet recruitingGlaucoma Following SurgeryUnited States
-
The New York Eye Surgery CenterOcular Therapeutix, Inc.TerminatedGlaucoma | CataractUnited States
-
Cathleen McCabe MDOcular Therapeutix, Inc.Terminated
-
University of Colorado, DenverPediatric Epilepsy Research Foundation; West Therapuetics, IncSuspended
-
Timothy PoteruchaPfizer; American Heart Association; Eidos Therapeutics, a BridgeBio companyRecruiting
-
First Affiliated Hospital of Wenzhou Medical UniversityShanghai First Song Therapeutics Co., LtdNot yet recruitingSystemic Sclerosis | Sjogren's Syndrome | Antiphospholipid Syndrome | ANCA Associated Vasculitis | Systemic Lupus Erythematosus (SLE) | Inflammatory MyopathyChina
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
Ryan Gentzler, MDMirati Therapeutics Inc.; University of VirginiaRecruitingAdagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain MetastasesNSCLC | Non Small Cell Lung Cancer | KRAS G12CUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...HuidaGene Therapeutics Co., Ltd.RecruitingLeber Congenital AmaurosisChina
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.Recruiting
-
Joseph TuscanoNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.Not yet recruiting
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Neoantigen Therapeutics Co., Ltd.RecruitingNeoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical ResectionResectable Esophageal CancerChina
-
Tianhong LiNational Cancer Institute (NCI); LabyRx Immunologic TherapeuticsRecruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Adenocarcinoma | Advanced Adenocarcinoma | Recurrent AdenocarcinomaUnited States
-
Icahn School of Medicine at Mount SinaiMerck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingNon-Hodgkin's Lymphoma | Metastatic Breast Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingChronic Lymphocytic Leukemia (CLL) | Refractory | RelapsedUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
City of Hope Medical CenterSangamo Therapeutics; California Institute for Regenerative Medicine (CIRM)Active, not recruiting
-
Jennifer Lee Caswell-JinNational Cancer Institute (NCI); QED Therapeutics, Inc.TerminatedBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
University of California, Los AngelesOrchard Therapeutics; California Institute for Regenerative Medicine (CIRM)CompletedSevere Combined Immunodeficiency Due to ADA DeficiencyUnited States
-
Seoul National University Bundang HospitalKorea University Guro Hospital; S-Alpha Therapeutics, Inc.CompletedAllergy and ImmunologyKorea, Republic of
-
Insight Therapeutics, LLCUniversity Hospitals Cleveland Medical Center; Case Western Reserve University and other collaboratorsActive, not recruiting
-
Kang YUCARsgen Therapeutics Co., Ltd.Active, not recruitingHepatocellular Carcinoma | B Cell Lymphoma | Pancreatic Carcinoma | Myeloma | B Cell Leukemia | Adenocarcinoma of Esophagogastric JunctionChina
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCompletedHypogonadismUnited States
-
Hammond, H. Kirk, M.D.National Heart, Lung, and Blood Institute (NHLBI); Renova TherapeuticsCompleted
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier TherapeuticsTerminatedBladder CancerUnited States
-
Kartos Therapeutics, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingEndometrial CancerUnited States, Austria, Spain, Israel, Denmark, Sweden, Slovenia, Finland, Georgia, Italy, Romania, Poland, Canada, Estonia, Hungary, Lithuania, Norway
-
University of ManitobaSickKids Foundation; The Canadian Collaborative for Childhood Cannabinoid Therapeutics...Recruiting
-
Colin D. Weekes, M.D., PhDActuate Therapeutics Inc.; Lustgarten FoundationRecruitingPancreatic Adenocarcinoma | Pancreatic Adenocarcinoma MetastaticUnited States
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics IncRecruitingRefractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Leukemia of Ambiguous Lineage in Relapse | Refractory Acute Leukemia of Ambiguous LineageUnited States
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States
-
Microvascular Therapeutics, LLCNational Heart, Lung, and Blood Institute (NHLBI); University of NebraskaRecruitingHeart DiseasesUnited States
-
Help TherapeuticsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...Recruiting
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | ccRCC | RCCUnited States
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingVHL - Von Hippel-Lindau Syndrome | VHL Gene Mutation | VHL Syndrome | VHL Gene Inactivation | VHL-Associated Renal Cell Carcinoma | VHL-Associated Clear Cell Renal Cell CarcinomaUnited States, Denmark, United Kingdom, France
-
Canadian Medical and Surgical Knowledge Translation...HLS Therapeutics, Inc; Amarin CorporationCompletedCOVID-19 | Inflammatory ResponseCanada
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCompletedHypogonadismUnited States